KZKatarina Zlatić

Katarina Zlatić

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katarina Zlatić has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Light drives bidirectional two-electron transfer between paired dynamic redox molecules

    by Anna Vasiļevska, Soňa Boháčová, Katarina Zlatić, Tomáš Slanina

    We demonstrate closed photoredox systems in which light alone drives a net two-electron transfer between pairs of dynamic redox (dyrex) switches. The same pair can be cycled between two thermodynamically stable states using light of orthogonal wavelengths, so the direction of two-electron transfer is set optically rather than by an external bias. The system is closed, requiring no sacrificial oxidant or reductant. The quantum yield of two-electron transfer exceeds unity through a combination of photoexcitation and potential inversion of the dyrex pair. This system provides directional, multi-electron control by light at the molecular level, a capability with no precedent in molecular redox chemistry.


  • Open Access

    Light drives bidirectional two-electron transfer between paired dynamic redox molecules

    by Anna Vasiļevska, Soňa Boháčová, Katarina Zlatić, Tomáš Slanina

    We demonstrate closed photoredox systems in which light alone drives a net two-electron transfer between pairs of dynamic redox (dyrex) switches. The same pair can be cycled between two thermodynamically stable states using light of orthogonal wavelengths, so the direction of two-electron transfer is set optically rather than by an external bias. The system is closed, requiring no sacrificial oxidant or reductant. The quantum yield of two-electron transfer exceeds unity through a combination of photoexcitation and potential inversion of the dyrex pair. This system provides directional, multi-electron control by light at the molecular level, a capability with no precedent in molecular redox chemistry.

  • Competing Photocleavage on Boron and at the meso-Position in BODIPY Photocages

    by Ivan Ljubić, Igor Sviben, Vedran Brusar, Katarina Zlatić, Silvije Vdović, Nikola Basarić

    BODIPY photocages (photocleavable protective groups) have stirred interest because they can release biologically active cargo upon visible light excitation. We conducted combined theoretical and experimental investigations on selected BODIPY photocages to elucidate the mechanism of the competing photocleavage at the boron and meso-position. Based on the computations, the former reaction involves elongation of the B-C bond, yielding a tight borenium cation and methyl anion. These ions are intercepted by CH3OH, enabling an efficient proton-coupled electron transfer (PCET) to produce the methane and isolated ether photoproducts. Singlet and triplet excited-state lifetimes were measured in CH3OH and CD3OD to probe the kinetic isotope effects (KIEs). The resulting KIEs are small, implying that the kinetic bottleneck is due to the C-B bond scission rather than the subsequent PCET. The introduction of a methoxy group in the meso-phenoxy substituent redirects the photosubstitution toward the meso-position. The corresponding regiochemistry was explained computationally. On elongating the C-O bonds in the S1 state, it is found that the unproductive conical intersection is encountered much earlier for the alkyl-O bond than for the phenyl-O bond. The current findings are valuable for the rational design of new BODIPY photocages with tailored biological applications.


  • Open Access

    Design, Synthesis and Biological Activity of Novel Methoxy- and Hydroxy-Substituted N-Benzimidazole-Derived Carboxamides

    by Anja Beč, Katarina Zlatić, Mihailo Banjanac, Vedrana Radovanović, Kristina Starčević, Marijeta Kralj, Marijana Hranjec

    This work presents the design, synthesis and biological activity of novel N-substituted benzimidazole carboxamides bearing either a variable number of methoxy and/or hydroxy groups. The targeted carboxamides were designed to investigate the influence of the number of methoxy and/or hydroxy groups, the type of substituent placed on the N atom of the benzimidazole core and the type of substituent placed on the benzimidazole core on biological activity. The most promising derivatives with pronounced antiproliferative activity proved to be N-methyl-substituted derivatives with hydroxyl and methoxy groups at the phenyl ring and cyano groups on the benzimidazole nuclei with selective activity against the MCF-7 cell line (IC50 = 3.1 μM). In addition, the cyano-substituted derivatives 10 and 11 showed strong antiproliferative activity against the tested cells (IC50 = 1.2–5.3 μM). Several tested compounds showed significantly improved antioxidative activity in all three methods compared to standard BHT. In addition, the antioxidative activity of 9, 10, 32 and 36 in the cells generally confirmed their antioxidant ability demonstrated in vitro. However, their antiproliferative activity was not related to their ability to inhibit oxidative stress nor to their ability to induce it. Compound 8 with two hydroxy and one methoxy group on the phenyl ring showed the strongest antibacterial activity against the Gram-positive strain E. faecalis (MIC = 8 μM).


  • Open Access

    Biological Activity of Amidino-Substituted Imidazo [4,5-b]pyridines

    by Ida Boček Pavlinac, Katarina Zlatić, Leentje Persoons, Dirk Daelemans, Mihajlo Banjanac, Vedrana Radovanović, Kristina Butković, Marijeta Kralj, Marijana Hranjec

    A series of cyano- and amidino-substituted imidazo[4,5-b]pyridines were synthesized using standard methods of organic synthesis, and their biological activity was evaluated. Biological evaluation included in vitro assessment of antiproliferative effects on a diverse selection of human cancer cell lines, antibacterial activity against chosen Gram-positive and Gram-negative bacterial strains, and antiviral activity on a broad panel of DNA and RNA viruses. The most pronounced antiproliferative activity was observed for compound 10, which contained an unsubstituted amidino group, and compound 14, which contained a 2-imidazolinyl amidino group; both displayed selective and strong activity in sub-micromolar inhibitory concentration range against colon carcinoma (IC50 0.4 and 0.7 μM, respectively). All tested compounds lacked antibacterial activity, with the exception of compound 14, which showed moderate activity against E. coli (MIC 32 μM). Bromo-substituted derivative 7, which contained an unsubstituted phenyl ring (EC50 21 μM), and para-cyano-substituted derivative 17 (EC50 58 μM) showed selective but moderate activity against respiratory syncytial virus (RSV).